View of 28590 – PREDICTIVE VALUE OF TUMORINFILTRATING LYMPHOCYTES FOR RESIDUAL DISEASE IN TRIPLE-NEGATIVE BREAST CANCER IN PATIENTS AFTER NEOADJUVANT CHEMOTHERAPY

Return to Article Details 28590 – PREDICTIVE VALUE OF TUMORINFILTRATING LYMPHOCYTES FOR RESIDUAL DISEASE IN TRIPLE-NEGATIVE BREAST CANCER IN PATIENTS AFTER NEOADJUVANT CHEMOTHERAPY Download Download PDF